<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">25238331</PMID>
        <DateCompleted>
            <Year>2015</Year>
            <Month>08</Month>
            <Day>31</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2019</Year>
            <Month>01</Month>
            <Day>08</Day>
        </DateRevised>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1557-8577</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>17</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Dec</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Rejuvenation research</Title>
                <ISOAbbreviation>Rejuvenation Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Curcumin's neuroprotective efficacy in Drosophila model of idiopathic Parkinson's disease is phase specific: implication of its therapeutic effectiveness.</ArticleTitle>
            <Pagination>
                <MedlinePgn>481-9</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1089/rej.2014.1591</ELocationID>
            <Abstract>
                <AbstractText>Selective degeneration of dopaminergic neurons in the substantia nigra underlies the basic motor impairments of Parkinson's disease (PD). Curcumin has been used for centuries in traditional medicines in India. Our aim is to understand the efficacy of genotropic drug curcumin as a neuroprotective agent in PD. Analysis of different developmental stages in model organisms revealed that they are characterized by different patterns of gene expression which is similar to that of developmental stages of human. Genotropic drugs would be effective only during those life cycle stages for which their target molecules are available. Hence there exists a possibility that targets of genotropic compounds such as curcumin may not be present in all life stages. However, no reports are available in PD models illustrating the efficacy of curcumin in later phases of adult life. This is important because this is the period during which late-onset disorders such as idiopathic PD set in. To understand this paradigm, we tested the protective efficacy of curcumin in different growth stages (early, late health stage, and transition phase) in adult Drosophila flies. Results showed that it can rescue the motor defects during early stages of life but is ineffective at later phases. This observation was substantiated with the finding that curcumin treatment could replenish depleted brain dopamine levels in the PD model only during early stages of life cycle, clearly suggesting its limitation as a therapeutic agent in late-onset neurodegenerative disorders such as PD.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Phom</LastName>
                    <ForeName>Limamanen</ForeName>
                    <Initials>L</Initials>
                    <AffiliationInfo>
                        <Affiliation>1 Drosophila Neurobiology Laboratory, Department of Zoology, Nagaland University (Central) , Lumami, Nagaland, India .</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Achumi</LastName>
                    <ForeName>Bovito</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Alone</LastName>
                    <ForeName>Debasmita P</ForeName>
                    <Initials>DP</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Muralidhara</LastName>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yenisetti</LastName>
                    <ForeName>Sarat Chandra</ForeName>
                    <Initials>SC</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
                <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Rejuvenation Res</MedlineTA>
            <NlmUniqueID>101213381</NlmUniqueID>
            <ISSNLinking>1549-1684</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>IT942ZTH98</RegistryNumber>
                <NameOfSubstance UI="D003474">Curcumin</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>PLG39H7695</RegistryNumber>
                <NameOfSubstance UI="D010269">Paraquat</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>VTD58H1Z2X</RegistryNumber>
                <NameOfSubstance UI="D004298">Dopamine</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D002851" MajorTopicYN="N">Chromatography, High Pressure Liquid</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003474" MajorTopicYN="N">Curcumin</DescriptorName>
                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName>
                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004331" MajorTopicYN="N">Drosophila melanogaster</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D004351" MajorTopicYN="N">Drug Resistance</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008136" MajorTopicYN="N">Longevity</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D009068" MajorTopicYN="N">Movement</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName>
                <QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010269" MajorTopicYN="N">Paraquat</DescriptorName>
                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
                <QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>9</Month>
                <Day>20</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>9</Month>
                <Day>23</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2015</Year>
                <Month>9</Month>
                <Day>1</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25238331</ArticleId>
            <ArticleId IdType="doi">10.1089/rej.2014.1591</ArticleId>
            <ArticleId IdType="pmc">PMC4270111</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>Biofactors. 2013 Jan-Feb;39(1):133-40</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23325575</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Death Differ. 2010 Jul;17(7):1115-25</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20094060</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Brain Res. 2003 Jun 27;976(2):243-52</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12763259</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Exp Gerontol. 2013 Feb;48(2):229-39</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23063786</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Gerontol A Biol Sci Med Sci. 2002 Nov;57(11):B390-8</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12403794</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Phytother Res. 2012 Dec;26(12):1857-63</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22422620</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurol Sci. 2002 Sep;23 Suppl 2:S119-20</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12548372</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Biol. 2004 May 4;14(9):782-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15120069</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Pharmacol Res. 2011 May;63(5):439-44</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21237271</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Rejuvenation Res. 2010 Oct;13(5):561-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20645870</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurobiol Aging. 2014 May;35(5):1162-76</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24315037</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cell Tissue Res. 2004 Oct;318(1):225-41</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">15258850</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Cancer Res Treat. 2014 Jan;46(1):2-18</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24520218</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Neurology. 1998 May;50(5):1346-50</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">9595985</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Phytother Res. 2014 May;28(5):656-72</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23943274</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>BMC Neurosci. 2010;11:57</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20433710</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Science. 1996 Nov 15;274(5290):1197-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">8895469</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Biochem. 2002 Apr;131(4):565-70</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">11926994</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Pharm Des. 2012;18(1):91-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22211691</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Curr Biol. 2002 Apr 30;12(9):712-23</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">12007414</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Evid Based Complement Alternat Med. 2014;2014:967462</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24790636</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Parkinsons Dis. 2012;2012:938528</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22900232</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>